|
|
 |
 |
 |
 |
|
|
Zusammenfassungen von Publikationen
|
 |
Clinical Effects of Treatment for Hypogonadism in Male Adolescents with Prader-Labhart-Willi Syndrome. Hormone Research 2007;68(4):178-184. Eiholzer U, Grieser J, Schlumpf M, l'Allemand D.
|
 |
Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. Journal of Clinical Endocrinology & Metabolism 2006;91:892-898. Eiholzer U, L'Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, Grüters A, Simoni M.
|
 |
A daily comprehensive muscle training programme increases lean mass and spontaneos activity in children with Prader-Willi syndrome after 6 months. Journal of Pediatric Endocrinology & Metabolism 2006;19:65-74. Schlumpf M, Eiholzer U, Gygax M, Schmid S, van der Sluis I, l'Allemand D.
|
 |
Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Hormone Research 2005;63:33-39. Eiholzer U.
|
 |
Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome. Journal of Pediatrics 2004;144:753-8. Eiholzer U, L'Allemand D, Schlumpf M, Rousson V, Gasser T, Fusch C.
|
 |
A comprehensive team approach to the management of patients with Prader-Willi syndrome. Journal of Pediatric Endocrinology & Metabolism 2004;17:1153-75. Eiholzer U, Whitman BY.
|
 |
Behavioural and emotional disturbances in people with Prader-Willi syndrome. Journal of Intellectual Disability Research 2004;48:47-52. Steinhausen HC, Eiholzer U, Hauffa BP, Malin Z.
|
 |
Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome. Hormone Research 2003;59:239-248. L'Allemand D, Eiholzer U, Schlumpf M, Torresani T, Girard J.
|
 |
Improving body composition and physical activity in Prader-Willi Syndrome. Journal of Pediatrics 2003; 142: 73-8. Eiholzer U, Nordmann Y, l'Allemand D, Schlumpf M, Schmid S, Kromeyer-Hauschild.
|
 |
Increased adrenal androgen levels in patients with prader-willi syndrome are associated with insulin, igf-I, and leptin, but not with measures of obesity. Hormone Research 2002; 58: 215-22. L'Allemand D, Eiholzer U, Rousson V, Girard J, Blum W, Torresani T, Gasser T.
|
 |
Sudden death of an infant with Prader-Willi syndrome - not a unique case? Biology of the Neonate 2002; 82: 139-41. Nordmann Y, Eiholzer U, L'Allemand D, Mirjanic S, Markwalder C.
|
 |
Fatal Outcome of Sleep Apnoea in PWS during the Initial Phase of Growth Hormone Treatment. A case report. Hormone Research 2002; 58 Suppl 3: 24-6. Eiholzer U, Nordmann Y, l'Allemand D.
|
 |
Behavioral phenotypes in four mental retardation syndromes: Fetal alcohol syndrome, Prader-Willi syndrome, fragile X syndrome, and tuberosis sclerosis. American Journal of Medical Genetics 2002; 111: 381-7. Steinhausen HC, Von Gontard A, Spohr HL, Hauffa BP, Eiholzer U, Backes M, Willms J, Malin Z.
|
 |
Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with Prader-Willi Syndrome after 4 Years of Therapy. Hormone Research 2000;53:185-192. Urs Eiholzer, Dagmar l'Allemand.
|
 |
Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome. European Journal of Pediatrics (2000) 159:835-842. D. l'Allemand, U. Eiholzer, M. Schlumpf, H. Steinert, W. Riesen.
|
 |
Body Composition Abnormalities in Children with Prader-Willi Syndrome and Long-Term Effects of Growth Hormone Therapy. Hormone Research 2000;53:200-206. U. Eiholzer, D. l'Allemand, I. van der Sluis, H. Steinert, T. Gasser, K. Ellis.
|
 |
Familial Dysalbuminemic Hyperthyroxinemia in a Swiss Family Caused by a Mutant Albumin (R218P) Shows an Apparent Discrepancy between Serum Concentration and Affinity for Thyroxine. The Journal of Clinical Endocrinology & Metabolism (2000) Vol. 85:2281-2286, No. 8. Silvana Pannain, Michael Feldman, Urs Eiholzer, Roy E. Weiss, Neal H. Scherberg, Samuel Refetoff.
|
 |
Male Hypogonadism Caused by Homozygous Deletion of Exon 10 of the Luteinizing Hormone (LH) Receptor: Differential Action of Human Chorionic Gonadotropin and LH.The Journal of Clinical Endocrinology & Metabolism (2000) Vol. 85:2281-2286, No. 6. J. Gromoll, U. Eiholzer, E. Nieschlag, M. Simoni.
|
 |
Does growth hormone therapy improve motor development in infants with Prader-Willi syndrome? European Journal of Pediatrics (2000) 159: 299-301. Urs Eiholzer, Sigrun Malich, Dagmar I'Allemand.
|
 |
Symptomatic versus substitution growth hormone therapy in short children: from auxology towards a comprehensive multidimensional assessment of short stature and related interventions. Journal of Pediatric Endocrinology & Metabolism 2000; 13: 403-8. Haverkamp F, Eiholzer U, Ranke MB, Noeker M.
|
 |
Phenotypic heterogeneity of growth and psychometric intelligence in Prader-Willi syndrome: variable expression of a contiguous gene syndrome or parent-child resemblance? American Journal of Medical Genetics 2000; 91: 298-304. Malich S, Largo R, Schinzel A, Molinari L, Eiholzer U.
|
 |
Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart- Willi syndrome. European Journal of Pediatrics 1999;134:222-5. Urs Eiholzer, MD, Werner F. Blum, MD, Luciano Molinari, PhD.
|
 |
Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome. European Journal of Pediatrics (1998) 157: 890-893. U. Eiholzer, K. Stutz, C. Weinmann, T. Torresani, L. Molinari, A. Prader.
|
 |
Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance. European Journal of Pediatrics (1998) 157: 368 - 377. U. Eiholzer, R. Gisin, C. Weinmann, S. Kriemler, H. Steinert T. Torresani, M. Zachmann, A. Prader.
|
 |
Longitudinal monthly body measurements from 1 to 12 months of age: a study by practitioners for practitioners. European Journal of Pediatrics (1998) 157: 547-552. U. Eiholzer, P. Bodmer, M. Bühler, U. Döhmann, G. Meyer, P. Reinhard, G. Schimert, G. Varga, R. Wälli, R. Largo, L. Molinari.
|
|

|
|
 |